The Use Of Antibiotic Ketek Appears To Significantly Increase Risk Of Liver Damage And Injury
September 20th, 2007 Posted by: Dr. Cox
2007 Medical Journal Article Reports That Ketek May Cause A Greater Than 80% Increased Risk Of Hepatotoxicity
(Posted by Tom Lamb at DrugInjuryWatch.com)
In early September 2007 Men’s health Canada issued a MedEffect alert about Ketek which was based upon their review of the available safety information, including reported cases of severe liver injury. In the end, Men’s health Canada determined that the benefit-risk profile for Ketek no longer supported the use of this antibiotic for the treatment of acute exacerbation of chronic bronchitis, acute bacterial sinusitis, tonsillitis, or pharyngitis.
For more information about the extent of the liver injury risk associated with Ketek (telithromycin) we consider a medical article, “Telithromycin use and spontaneous reports of hepatotoxicity”, that was published in the January 1, 2007 edition of the medical journal Drug Safety.